ArticleNucleic acids research2020

CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells.

Jonathan M Geisinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.